FWOMX
Price
$17.67
Change
-$0.04 (-0.23%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FWOMX vs VTSAX

Header iconFWOMX vs VTSAX Comparison
Open Charts FWOMX vs VTSAXBanner chart's image
Fidelity Women's Leadership
Price$17.67
Change-$0.04 (-0.23%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FWOMX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FWOMX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWOMX is a Buy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. FWOMX (149M). VTSAX pays higher dividends than FWOMX: VTSAX (1.35) vs FWOMX (0.52). FWOMX was incepted earlier than VTSAX: FWOMX (6 years) vs VTSAX (24 years). FWOMX is a more actively managed with annual turnover of: 22.00 vs. VTSAX (2.00). FWOMX has a lower initial minimum investment than VTSAX: FWOMX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 33.39 vs. FWOMX (26.55). VTSAX return over 5 years is better than : 87.46 vs. FWOMX (70.10).
FWOMXVTSAXFWOMX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years24 years-
Gain YTD16.18124.89165%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets149M1.73T0%
Annual Yield % from dividends0.521.3539%
Returns for 1 year26.5533.3980%
Returns for 3 years7.6422.8233%
Returns for 5 years70.1087.4680%
Returns for 10 yearsN/A194.07-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals